Enwei Pharmaceutical Co., Ltd. (SHE:301331)
China · Delayed Price · Currency is CNY 36.54
+0.52 (1.44%)
At close: Aug 22, 2025, 2:57 PM CST
Enwei Pharmaceutical Market Cap
Enwei Pharmaceutical has a market cap or net worth of 3.69 billion as of August 22, 2025. Its market cap has increased by 75.90% in one year.
Market Cap
3.69B
Enterprise Value
3.37B
Revenue
825.15M
Ranking
n/a
PE Ratio
80.92
Stock Price
36.54
Market Cap Chart
Since September 21, 2022, Enwei Pharmaceutical's market cap has increased from 3.07B to 3.69B, an increase of 20.42%. That is a compound annual growth rate of 6.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 3.69B | 60.07% |
| Dec 31, 2024 | 2.31B | -20.75% |
| Dec 29, 2023 | 2.91B | 4.40% |
| Dec 30, 2022 | 2.79B | -9.08% |
| Sep 21, 2022 | 3.07B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 432.34B |
| Shenzhen Mindray Bio-Medical Electronics | 295.39B |
| WuXi AppTec | 275.20B |
| Sichuan Biokin Pharmaceutical | 133.02B |
| Zhangzhou Pientzehuang Pharmaceutical., | 129.26B |
| Aier Eye Hospital Group | 124.56B |
| Shanghai United Imaging Healthcare | 111.01B |
| Yunnan Baiyao Group Co.,Ltd | 102.84B |